Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors.
about
Activation of compensatory pathways via Rac2 in the absence of the Cdc42 effector Wiskott-Aldrich syndrome protein in Dendritic cells.Tissue-selective expression of a conditionally-active ROCK2-estrogen receptor fusion protein.Regulation of RhoA GTPase and novel target proteins for ROCK.The Rac GTPase in Cancer: From Old Concepts to New Paradigms.Discovery of potent and selective MRCK inhibitors with therapeutic effect on skin cancer.
P2860
Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rho GTPases, their post-transl ...... nd pharmacological inhibitors.
@en
type
label
Rho GTPases, their post-transl ...... nd pharmacological inhibitors.
@en
prefLabel
Rho GTPases, their post-transl ...... nd pharmacological inhibitors.
@en
P2860
P921
P1476
Rho GTPases, their post-transl ...... nd pharmacological inhibitors.
@en
P2860
P304
P356
10.1080/21541248.2016.1218407
P577
2016-08-22T00:00:00Z
2018-05-04T00:00:00Z